These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15990299)

  • 1. Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. Part 3: Chemical derivatization.
    Mariani R; Granata G; Maffioli SI; Serina S; Brunati C; Sosio M; Marazzi A; Vannini A; Patel D; White R; Ciabatti R
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3748-52. PubMed ID: 15990299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. II. Structure elucidation.
    Marazzi A; Kurz M; Stefanelli S; Colombo L
    J Antibiot (Tokyo); 2005 Apr; 58(4):260-7. PubMed ID: 15981412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action of the microbial metabolite GE23077, a novel potent and selective inhibitor of bacterial RNA polymerase.
    Sarubbi E; Monti F; Corti E; Miele A; Selva E
    Eur J Biochem; 2004 Aug; 271(15):3146-54. PubMed ID: 15265034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase.
    Lira R; Xiang AX; Doundoulakis T; Biller WT; Agrios KA; Simonsen KB; Webber SE; Sisson W; Aust RM; Shah AM; Showalter RE; Banh VN; Steffy KR; Appleman JR
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6797-800. PubMed ID: 17980587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. I. Taxonomy, isolation and characterization.
    Ciciliato I; Corti E; Sarubbi E; Stefanelli S; Gastaldo L; Montanini N; Kurz M; Losi D; Marinelli F; Selva E
    J Antibiot (Tokyo); 2004 Mar; 57(3):210-7. PubMed ID: 15152807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new class of small molecule RNA polymerase inhibitors with activity against rifampicin-resistant Staphylococcus aureus.
    Arhin F; Bélanger O; Ciblat S; Dehbi M; Delorme D; Dietrich E; Dixit D; Lafontaine Y; Lehoux D; Liu J; McKay GA; Moeck G; Reddy R; Rose Y; Srikumar R; Tanaka KS; Williams DM; Gros P; Pelletier J; Parr TR; Far AR
    Bioorg Med Chem; 2006 Sep; 14(17):5812-32. PubMed ID: 16759869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An RNA polymerase inhibitor, cyclothiazomycin B1, and its isomer.
    Hashimoto M; Murakami T; Funahashi K; Tokunaga T; Nihei K; Okuno T; Kimura T; Naoki H; Himeno H
    Bioorg Med Chem; 2006 Dec; 14(24):8259-70. PubMed ID: 17010619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of a macrocyclic inhibitor for peptide deformylase.
    Hu X; Nguyen KT; Verlinde CL; Hol WG; Pei D
    J Med Chem; 2003 Aug; 46(18):3771-4. PubMed ID: 12930137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of microcin J25, a peptide inhibitor of bacterial RNA polymerase, is a lassoed tail.
    Wilson KA; Kalkum M; Ottesen J; Yuzenkova J; Chait BT; Landick R; Muir T; Severinov K; Darst SA
    J Am Chem Soc; 2003 Oct; 125(41):12475-83. PubMed ID: 14531691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel small molecule inhibitors targeting the "switch region" of bacterial RNAP: structure-based optimization of a virtual screening hit.
    Sahner JH; Groh M; Negri M; Haupenthal J; Hartmann RW
    Eur J Med Chem; 2013 Jul; 65():223-31. PubMed ID: 23711833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel bacterial RNA polymerase inhibitors: pharmacophore-based virtual screening and hit optimization.
    Hinsberger S; Hüsecken K; Groh M; Negri M; Haupenthal J; Hartmann RW
    J Med Chem; 2013 Nov; 56(21):8332-8. PubMed ID: 24112046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel propeptin analog, propeptin-2, missing two amino acid residues from the propeptin C-terminus loses antibiotic potency.
    Kimura K; Yamazaki M; Sasaki N; Yamashita T; Negishi S; Nakamura T; Koshino H
    J Antibiot (Tokyo); 2007 Aug; 60(8):519-23. PubMed ID: 17827663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New inhibitors targeting bacterial RNA polymerase.
    Darst SA
    Trends Biochem Sci; 2004 Apr; 29(4):159-60. PubMed ID: 15124627
    [No Abstract]   [Full Text] [Related]  

  • 14. Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation.
    Doundoulakis T; Xiang AX; Lira R; Agrios KA; Webber SE; Sisson W; Aust RM; Shah AM; Showalter RE; Appleman JR; Simonsen KB
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5667-72. PubMed ID: 15482944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp.
    Igarashi M; Sawa R; Kinoshita N; Hashizume H; Nakagawa N; Homma Y; Nishimura Y; Akamatsu Y
    J Antibiot (Tokyo); 2008 Jun; 61(6):387-93. PubMed ID: 18667787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to skipped polyene macrolides through ring-closing metathesis: total synthesis of the RNA polymerase inhibitor ripostatin B.
    Winter P; Hiller W; Christmann M
    Angew Chem Int Ed Engl; 2012 Apr; 51(14):3396-400. PubMed ID: 22337614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-molecular weight inhibitors of bacterial DNA-dependent RNA polymerase].
    Zorov SD; Iuzenkova IuV; Severinov KV
    Mol Biol (Mosk); 2006; 40(6):971-81. PubMed ID: 17209424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and structure-activity relationship studies of new phenolic DNA gyrase inhibitors.
    Lübbers T; Angehrn P; Gmünder H; Herzig S
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4708-14. PubMed ID: 17632001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydocin analogs bearing carbonyl group as possible ligand toward zinc atom in histone deacetylases.
    Bhuiyan MP; Kato T; Okauchi T; Nishino N; Maeda S; Nishino TG; Yoshida M
    Bioorg Med Chem; 2006 May; 14(10):3438-46. PubMed ID: 16439135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.
    Gomez L; Hack MD; Wu J; Wiener JJ; Venkatesan H; Santillán A; Pippel DJ; Mani N; Morrow BJ; Motley ST; Shaw KJ; Wolin R; Grice CA; Jones TK
    Bioorg Med Chem Lett; 2007 May; 17(10):2723-7. PubMed ID: 17368897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.